View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 17, 2019

CMR Surgical raises £195m in Series C round

UK-based medical robotics company CMR Surgical has raised £195m in its Series C funding round, pushing the company value to over £1bn before the launch of its first product.

By Chloe Kent

UK-based medical robotics company CMR Surgical has raised £195m in its Series C funding round, pushing the company value to over £1bn before the launch of its first product.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The Series C round is Europe’s largest private funding round in the medical technology sector to date, according to CMR.

The money is intended to fully fund the global commercialisation of the business, with the launch of the company’s Versius surgical robot across Europe and Asia scheduled imminently. It will also be used to support continued research and development, manufacturing and expansion of the product in other regions.

The Versius robot is designed to make minimal access surgery (MAS) easier to perform by using individual cart-mounted arms to perform surgery, rather than directly operated handheld tools. A surgeon can sit or stand at Versius’ 3D-HD vision open console, reducing physical strain on the operator during the procedure.

These factors mean Versius could shorten the overall learning curve for keyhole procedures from two or three years to a matter of weeks.

The product can be used for a broad range of MAS procedures, which are associated with reduced pain during healing, shorter hospital stays and fewer complications.

CMR successfully completed 30 first-in-human surgical procedures in May 2019 at Mangeshkar Hospital & Research Center in Pune, India. The surgeons did not find any Versius-related adverse events at a 30-day follow-up in any of the minor, intermediate or major gynaecological and upper gastrointestinal operations performed.

CMR Surgical chief executive Martin Frost said: “We are delighted with the level of interest and support we have received from both new and existing investors. This is a really exciting time for CMR, having already completed a series of surgical procedures using Versius in a clinical trial, and we are on the verge of the commercial launch of the Versius system. We are strongly positioned to transform the global market of minimal access surgery, making it more accessible and affordable.”

The $3.7bn global robotic-assisted MAS market is currently growing at 19% a year.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network